Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 11,180

Document Document Title
WO/2017/101793A1
The invention belongs to the field of biomedical research involving the 1, 3, 4- selenyldiazo derivatives that have cell protective activity. Because there are not so many heterocyclic selenium compounds, we synthesized a new type of sel...  
WO/2017/103348A1
The invention relates to a liquid composition comprising at least one mucosa-lining agent, at least one humectant, and at least one pH adjuster. The invention also relates to the use of said composition as a nasal solution in the prevent...  
WO/2017/104777A1
A purpose of the present invention is to provide: a composition for inhibiting carnosine dipeptidase, use of said composition for inhibiting carnosine dipeptidase, and a method for inhibiting carnosine dipeptidase. Another purpose of the...  
WO/2017/100915A1
There is provided an improved extraction process for obtaining integral & active thylakoid membranes that have longer shelf-life at room temperature. Particularly, the extract is lyophilized in a solution of PVP and remains stable with a...  
WO/2017/101887A1
A healthcare pharmaceutical preparation having magnesium supplementation and anti-oxidation effects, and a preparation method for the healthcare pharmaceutical preparation. The healthcare pharmaceutical preparation comprises a main effec...  
WO/2017/101873A1
An application of plasminogen for preventing, treating, improving and/or eliminating radiation and chemical damage and associated diseases in a subject, further providing a novel treatment strategy for treating different types of radiati...  
WO/2017/097182A1
The present invention discloses quinoline compounds, a preparation method thereof, and a use thereof as a urate transporter inhibitor drug. The compounds and salts, hydrates or solvates thereof provided in the present invention, as a sel...  
WO/2017/095489A1
This invention generally relates to a composition and method for inducing the expansion and/or regeneration of CD34-positive adult stem cell population, which is useful for developing drugs/vaccines and/or therapies against a variety of ...  
WO/2017/095458A1
This invention generally relates to a composition and method of using recombinant microRNAs (miRNA) and their hairpin-like precursors (pre-miRNA) as therapeutic drugs for treating Alzheimer's diseases (AD). More specifically, the present...  
WO/2017/094549A1
Provided are a novel ultraviolet-ray screening agent and a novel cosmetic each having a high level of ultraviolet-ray screening function. The inventors have found that an extract from an olive branch has a high level of effect of absorbi...  
WO/2017/092638A1
The present invention relates to an opioid receptor antagonist derivative, a preparation method thereof and a use thereof in medicine. In particular, the present invention relates to a naloxone derivative as shown by general formula (I) ...  
WO/2017/084431A1
The present invention provides a composition for removing harmful reactive oxygen from a human body, which is composed of 7-hydroxycoumarin for removing superoxide radical O2 and resveratrol for removing hydrogen peroxide H2O2, the 7-hyd...  
WO/2017/087795A1
This invention relates to novel α-tocotrienol quinones of Formula I: (I), and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions ...  
WO/2017/080669A1
The present invention provides a pharmaceutical preparation for use by injection into the skin, wherein the pharmaceutical preparation is preparable by a production method comprising the steps of providing a liquid collected from an orga...  
WO/2017/080668A1
The present invention relates a pharmaceutical preparation for the treatment of age- related disorders, which is preparable by a production method comprising the following steps: providing a liquid collected from an organism, which liqui...  
WO/2017/083776A1
The invention provides for AAV vectors expressing the ANO5 gene and antioxidant therapy as methods of inducing muscle regeneration and a method of treating muscular dystrophy.  
WO/2017/075696A1
Mycotoxin-deactivating aptamers, especially DNA aptamers, bind to mycotoxins in feed and feed ingredients resulting in the reduction or elimination of toxic and carcinogenic effects of mycotoxins. The invention also discloses a compositi...  
WO/2017/079455A1
Disclosed herein is the novel use of use of a Bauhinia spp. extract, which may upregulate neprilysin, induce autophagy, protect neuron from amyloidopathy or tauopathy, and/or promote neurite outgrowth, thus the Bauhinia spp. extract of t...  
WO/2017/077516A2
The invention relates to compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions, particularly wherein said telomere related diseases and/or telomere related medical conditions are cance...  
WO/2017/075899A1
The present invention provides an application of a PprI protein in preparation of a drug for prevention and treatment of radiation damage of higher eukaryotes. The PprI protein can prevent and treat acute radiation damage of human cells ...  
WO/2017/063328A1
A fullerene and/or metallofullerene micronano material and application thereof. The fullerene and/or metallofullerene micronano material has all the following properties: (1) the surface is hydrophilic, so that the micronano material is ...  
WO/2017/063064A1
The present invention relates to a method for producing an equine serum against the venom of Apis mellifera africanised bees, produced from the blood of hyperimmunised horses, and using as the antigen the main toxic fractions of the veno...  
WO/2017/060914A2
Penicillamine and its derivatives, composition, methods of synthesizing and using the compound of formula 1 are disclosed. The compounds of formula 1 also comprises of salts, polymorphs, solvates and hydrates thereof. The compounds may b...  
WO/2017/060914A3
Penicillamine and its derivatives, composition, methods of synthesizing and using the compound of formula 1 are disclosed. The compounds of formula 1 also comprises of salts, polymorphs, solvates and hydrates thereof. The compounds may b...  
WO/2017/062311A1
Compositions for addressing one or more of the effects of aging are described. The compositions comprise a first component comprising repair system activator(s) such as nicotinamide adenine dinucleotide (NAD+), nicotinamide mononucleotid...  
WO/2017/057647A1
Provided is a method for producing an olive leaf extract that contains a high concentration of oleuropein. The method according to the present invention for producing an olive leaf extract comprises a first step for grinding dried olive ...  
WO/2017/057768A1
The present invention addresses the problem of providing an intraocular perfusion solution that is able to adequately protect intraocular tissue during eye surgery, and which is highly safe. The problem is solved by an intraocular perfus...  
WO/2017/058063A1
The invention relates to an agent which has both a protective effect on healthy organs and tissues and an adjuvant effect during radiotherapy and chemotherapy.  
WO/2017/051585A1
[Problem] To provide an inhaling fragrance that can be taken in other than through oral administration. [Solution] The inhaling fragrance includes leaf alcohol and linalool, includes ethanol as a primary solvent, and is liquid at normal ...  
WO/2017/050298A1
The present invention relates to compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof.  
WO/2017/045034A1
The present invention provides an advantageous formulation of ubiquinone (CoQ10) and/or ubiquinol with greater bioavailability, thereby allowing for high concentrations of CoQ10 and/or ubiquinol to be absorbed with lesser volumes of the ...  
WO/2017/042267A1
The present invention relates to the use of compounds for the prevention and treatment of diseases whose initiation and/or evolution relates to the production and effects of reactive oxygen species (ROS) of mitochondrial origin.  
WO/2017/024639A1
A Chinese medicine hangover curing agent. The agent is prepared from Chinese Hawthorn, Folium nelumbinis, Folium mori, Taraxaci herba, Lophatheri herba, common duckweed and tangerine leaves.  
WO/2017/022030A1
Provided is a method for producing an extract of Momordica charantia var. pavel, said extract containing less than 5 ppm of quinine. The method for producing an extract of M. charantia var. pavel comprises a cultivation step, a harvestin...  
WO/2017/021914A1
This document provides methods and materials for reducing the degree of damage to tissue transplanted into a mammal following transplantation. For example, methods and materials for using abscisic acid to reduce tissue damage to vascular...  
WO/2017/014340A1
The present invention relates to a composition containing Stephanandra incisa (Thunb.) Zabel extracts having an anti-aging efficacy and a use containing the same as an active ingredient. The present invention provides Stephanandra incisa...  
WO/2017/013492A1
The present disclosure provides compositions comprising 15-HEPE for use in treating and/or preventing cancer and neurological diseases in a subject in need thereof.  
WO2017010538A1
Provided are a carnosine dipeptidase 1 inhibitor composition, a use for a material that inhibits carnosine dipeptidase 1, and a method for inhibiting carnosine dipeptidase 1. The present invention demonstrates the discovery of a plant- o...  
WO2017008902A1
Pharmaceutically acceptable cholecalciferol sulfate salts are used for combating vitamin D3deficiency. The invention also relates to cholecalciferol sulfate salts and to pharmaceutical compositions of the pharmaceutically acceptable chol...  
WO2017010133A1
Provided are a carnosine dipeptidase 1 inhibitor composition, a use for a material that inhibits carnosine dipeptidase 1, and a method for inhibiting carnosine dipeptidase 1. The present invention demonstrates the discovery of a plant- o...  
WO/2017/009202A1
This invention relates generally to compositions and methods for combating inflammatory disease and particularly to the use of food and/or feed compositions for preventing, reducing and/or treating inflammatory disorders, diseases, or di...  
WO2017010537A1
Provided are a carnosine dipeptidase 1 inhibitor composition, a use for said composition in order to inhibit carnosine dipeptidase 1, and a method for inhibiting carnosine dipeptidase 1. The present invention demonstrates the discovery o...  
WO/2016/206363A1
A use of a Jilin ginseng oligopeptide in preparation of an anti-oxidant food product or a health care food product.  
WO/2016/210226A1
The present invention provides a formulation of Coenzyme Q10 that can be re-dispersed from a stable dry powder to formulation to yield a nanodispersion that can be readily aerosolized for inhalation.  
WO/2016/198401A1
A series of substituted indazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neuro...  
WO/2016/188766A1
The present invention relates to compounds for prophylaxis or treatment of organ damage by restoring endothelial function and/or inhibiting reactive oxygen species production and especially to compounds for prophylaxis or treatment of di...  
WO/2016/190750A1
Improving the antioxidant capacity in an animal by increasing the level of glutathione in the blood or tissue of the animal comprising providing a composition containing beta- casein to the animal for consumption, where the beta-casein c...  
WO/2016/187545A1
This invention relates to compositions and methods for treating, ameliorating and preventing the toxic effects of venom poisoning. In particular, the invention provides compositions comprising carbon monoxide releasing molecules (CORM) o...  
WO/2016/185403A1
The present application refers to the development of a new effective antidote for the poisonous Amanita mushroom species, after exploring an innovative in silico and in vivo approach based on the binding site of amatoxin to RNA polymeras...  
WO/2016/177309A1
Provided is a method for preparing a broccoli protein peptide. The method uses a broccoli protein as the raw material, and obtains a broccoli protein peptide powder through the steps of preprocessing, enzymatic hydrolysis, terminating en...  

Matches 1 - 50 out of 11,180